Advisors

Mark started his career in 1975 with Baxter Healthcare and continued there for more than 20 years, until he joined Allegiance Healthcare where he was a corporate officer responsible for Quality, Regulatory and R&D. During his time at Baxter, he worked in manufacturing operations for IV fluids, injectable drugs, simple medical devices and electronic infusion devices, and spent time expanding Baxter’s presence in Asia. At Baxter, Mr. Ehlert had P&L responsibility for a major hub of Asian operations. Mr. Ehlert retired as Corporate Vice President for Global Quality and Regulatory at Hospira, a world leader in generic injectable pharmaceuticals and medication management systems.

Today, Mr. Ehlert operates as an Independent Board member and Angel Investor. He currently sits on the Board of Directors of Stabilux Biosciences, Sterile State, Light Line Medical and BioQ Pharma. Mr. Ehlert received a B.S. in Microbiology from Michigan State University.